,24 Because the avidity of anti-Spike IgG responses gradually increased after the second vaccine dose in CVID responders, our results support a potential involvement of GCs and antigen-specific B cell selection in a subset of CVID patients, that could contribute to the generation of long-lived ASCs. The gene discussed is CHMP5; the disease is common variable immunodeficiency.